Companion Diagnostics Market to 2022 Global Major Manufacturers Production and Sales Market Comparison

Stakeholders of Companion Diagnostics Market are Pharmaceutical and biotechnology companies, Diagnostic manufacturers, Research laboratories and academic institutes, Research and development (R&D) companies and Clinical research organizations (CROs).

Top major market players in companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), and QIAGEN N.V. (Netherlands) dominated the global companion diagnostics market. Some of other players competing in market are Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Danaher Corporation (U.S.), Almac Group (U.S.), and Sysmex Corporation (Japan).

Download Sample Papers on Companion Diagnostics Market spread across 170 pages, Profiling 15 Companies and Supported with 105 Tables and 37 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=297416 .
The global Companion Diagnostics Market projected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. Growth of this market majorly driven by factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across globe, & increasing collaborations & partnerships for companion diagnostics test development.

Growth of companion diagnostics market majorly driven by factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across globe, and increasing collaborations and partnerships for companion diagnostics test development. Report analyzes the companion diagnostics market by product & service, technology, indication, end user, and region.

Get Free Assistance Now at Call +1 888 391 5441 / sales@reportsandreports.com .

The key factors driving companion diagnostics market growth include increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support companion diagnostics market. Report analyzes companion diagnostics market by product & service, technology, indication, end user, & region.

“Pharmaceutical & biopharmaceutical companies segment expected to grow at fastest CAGR”. On basis of end user, pharmaceutical & biopharmaceutical companies segment accounted for largest share of market in 2016. End-user segment expected to register highest CAGR during forecast period. Large share & growth of market can be attributed to increasing & significant application of companion diagnostics in drug development process.

Get 15% Discount Now on “Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=297416 .

Research Coverage:
The report analyzes the companion diagnostics market and aims at estimating market size and future growth potential of this market based on various segments such as product and service, type of medical device, application, and region. In 2016, the oncology segment accounted for the largest share and is also the fastest growing segment of the market.

The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

We provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

sales@reportsandreports.com / Call +1 888 391 5441

This release was published on openPR.